Targeting AP1S1 modulates the unfolded protein response and cell cycle and sensitizes triple-negative breast cancer to erlotinib

Tissue and Cell · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles